Cigna Exec Says It Is Working With Novo, Lilly On Changes In GLP-1 Drug Prices After White House Deal

Cigna Group +0.43% Post
Eli Lilly and Company +0.41% Post
Novo Nordisk A/S Sponsored ADR Class B +1.63% Post
ETF-S&P 500 +1.02% Post

Cigna Group

CI

268.35

268.35

+0.43%

0.00% Post

Eli Lilly and Company

LLY

989.12

987.01

+0.41%

-0.21% Post

Novo Nordisk A/S Sponsored ADR Class B

NVO

38.58

38.50

+1.63%

-0.21% Post

ETF-S&P 500

SPY

669.03

668.19

+1.02%

-0.13% Post

- Reuters Citing UBS Healthcare Conf

Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via